G1 Therapeutics Stock Forecast - Daily Balance Of Power
GTHXDelisted Stock | USD 7.15 0.00 0.00% |
GTHX Stock Forecast is based on your current time horizon.
GTHX |
Check G1 Therapeutics Volatility | Backtest G1 Therapeutics | Trend Details |
G1 Therapeutics Trading Date Momentum
On September 04 2024 G1 Therapeutics was traded for 7.13 at the closing time. The top price for the day was 7.13 and the lowest listed price was 7.09 . The trading volume for the day was 1.2 M. The trading history from September 4, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.56% . The overall trading delta against the current closing price is 0.56% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare G1 Therapeutics to competition
View G1 Therapeutics Related Equities
Risk & Return | Correlation |
G1 Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how G1 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading G1 Therapeutics shares will generate the highest return on investment. By undertsting and applying G1 Therapeutics stock market strength indicators, traders can identify G1 Therapeutics entry and exit signals to maximize returns.
Accumulation Distribution | 0.0028 | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 7.15 | |||
Day Typical Price | 7.15 | |||
Market Facilitation Index | 0.02 |
G1 Therapeutics Risk Indicators
The analysis of G1 Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in G1 Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gthx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.77 | |||
Semi Deviation | 1.98 | |||
Standard Deviation | 8.77 | |||
Variance | 76.95 | |||
Downside Variance | 12.66 | |||
Semi Variance | 3.91 | |||
Expected Short fall | (5.42) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in GTHX Stock
If you are still planning to invest in G1 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G1 Therapeutics' history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
CEOs Directory Screen CEOs from public companies around the world |